Experienced in Activated PI3K Delta Syndrome (APDS)

Remi H. Salomon

Paris, FR 
Experienced in Activated PI3K Delta Syndrome (APDS)
Paris, FR 
OverviewLocationsClinical Research

Overview

Remi Salomon practices in Paris, France. Ms. Salomon is rated as an Experienced expert by MediFind in the treatment of Activated PI3K Delta Syndrome (APDS). Her top areas of expertise are Lowe Syndrome, Nephronophthisis, Bilateral Renal Agenesis Dominant Type, Nephrotic Syndrome, and Kidney Transplant.

Her clinical research consists of co-authoring 93 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 1 article in the study of Activated PI3K Delta Syndrome (APDS).

Gender
Female

Locations

Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Multicentric, Prospective Open-label Study Assessing an Algorithm-based Strategy of Eculizumab Discontinuation in Children and Adults With Atypical Hemolytic Uremic Syndrome (aHUS)
Enrollment Status: Completed
Publish Date: December 06, 2019
Intervention Type: Drug
Study Phase: Phase 4
Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Early Treatment With the Monoclonal C5 Antibody Eculizumab in Pediatric Patients Affected by Shiga-toxin Related Hemolytic and Uremic Syndrome: A Phase III Prospective Randomized Controlled Therapeutic Trial Versus Placebo
Enrollment Status: Completed
Publish Date: July 12, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

93 Total Publications

Growth and rhGH use in children with congenital chronic kidney disease: a multicentric contemporary study.
Growth and rhGH use in children with congenital chronic kidney disease: a multicentric contemporary study.
Journal: Hormone research in paediatrics
Published: November 20, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Salomon's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 37 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile